Trial Information

Summary: Clinical trial to test a study drug in Adolescent Subjects with Steroid-Resistant Focal Segmental Glomerulosclerosis (FSGS)

This study is trying to find out whether a new, experimental medicine that has not been used in subjects with FSGS before can be given safely to subjects with FSGS. The study will look at how the body handles this medication by looking at side effects and by checking blood levels.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

• Be a male or female who is 12-15 years old; some females who are 10-11 years old may also be eligible
• Have a biopsy diagnosis of primary FSGS

• Are pregnant or breast-feeding
• Had an organ transplant
• Have a history of cancer, cardiovascular disease, diabetes mellitus, sickle cell disease, multiple sclerosis, systemic lupus, HIV, Hepatitis B and C
• Have planned elective surgery
• Participated in another clinical trial within 6 weeks, or received another study drug within 12 weeks, of starting the study drug

If you would like to learn more about participating in this study, please send an e-mail message using the form below.